Structure

Physi-Chem Properties

Molecular Weight:  322.08
Volume:  323.177
LogP:  4.159
LogD:  3.03
LogS:  -6.503
# Rotatable Bonds:  3
TPSA:  61.81
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.565
Synthetic Accessibility Score:  2.359
Fsp3:  0.105
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.674
MDCK Permeability:  4.466689642868005e-05
Pgp-inhibitor:  0.985
Pgp-substrate:  0.012
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.967

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.014
Plasma Protein Binding (PPB):  84.93695068359375%
Volume Distribution (VD):  0.555
Pgp-substrate:  11.480426788330078%

ADMET: Metabolism

CYP1A2-inhibitor:  0.969
CYP1A2-substrate:  0.953
CYP2C19-inhibitor:  0.855
CYP2C19-substrate:  0.129
CYP2C9-inhibitor:  0.749
CYP2C9-substrate:  0.935
CYP2D6-inhibitor:  0.667
CYP2D6-substrate:  0.947
CYP3A4-inhibitor:  0.847
CYP3A4-substrate:  0.289

ADMET: Excretion

Clearance (CL):  6.464
Half-life (T1/2):  0.149

ADMET: Toxicity

hERG Blockers:  0.046
Human Hepatotoxicity (H-HT):  0.361
Drug-inuced Liver Injury (DILI):  0.959
AMES Toxicity:  0.504
Rat Oral Acute Toxicity:  0.489
Maximum Recommended Daily Dose:  0.608
Skin Sensitization:  0.062
Carcinogencity:  0.749
Eye Corrosion:  0.003
Eye Irritation:  0.467
Respiratory Toxicity:  0.783

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC233776

Natural Product ID:  NPC233776
Common Name*:   2-(2,5-Dimethoxyphenyl)Furo[2,3-H]Chromen-4-One
IUPAC Name:   2-(2,5-dimethoxyphenyl)furo[2,3-h]chromen-4-one
Synonyms:  
Standard InCHIKey:  DLYWGMBSOSDGOR-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C19H14O5/c1-21-11-3-5-16(22-2)14(9-11)18-10-15(20)12-4-6-17-13(7-8-23-17)19(12)24-18/h3-10H,1-2H3
SMILES:  COc1ccc(c(c1)c1cc(=O)c2ccc3c(cco3)c2o1)OC
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3581064
PubChem CID:   11045499
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001615] Flavones
          • [CHEMONTID:0001759] Furanoflavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota stem bark Indonesia 1999-SEP PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. stem n.a. PMID[14510596]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota dry stem n.a. n.a. PMID[25466192]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota Roots n.a. n.a. PMID[29482940]
NPO30165 Pongamia pinnata Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO2398 Millettia erythrocalyx Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus IC50 = 87670.0 nM PMID[449666]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC233776 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9864 High Similarity NPC130015
0.9864 High Similarity NPC38361
0.9728 High Similarity NPC135303
0.9728 High Similarity NPC148423
0.9592 High Similarity NPC306788
0.9545 High Similarity NPC65846
0.9533 High Similarity NPC41719
0.953 High Similarity NPC472407
0.9524 High Similarity NPC198427
0.9456 High Similarity NPC190572
0.9355 High Similarity NPC193998
0.9338 High Similarity NPC263676
0.9333 High Similarity NPC472406
0.9211 High Similarity NPC253872
0.9167 High Similarity NPC264293
0.9145 High Similarity NPC116604
0.9139 High Similarity NPC88445
0.9125 High Similarity NPC190351
0.9114 High Similarity NPC38914
0.9079 High Similarity NPC191104
0.9062 High Similarity NPC41853
0.906 High Similarity NPC17262
0.9045 High Similarity NPC304387
0.9026 High Similarity NPC472462
0.902 High Similarity NPC170169
0.9007 High Similarity NPC304443
0.9007 High Similarity NPC74539
0.9 High Similarity NPC241820
0.9 High Similarity NPC167479
0.8968 High Similarity NPC198490
0.8957 High Similarity NPC66804
0.8954 High Similarity NPC230713
0.8954 High Similarity NPC78335
0.891 High Similarity NPC247677
0.891 High Similarity NPC160015
0.8903 High Similarity NPC1477
0.8903 High Similarity NPC213608
0.8903 High Similarity NPC122365
0.8903 High Similarity NPC183874
0.8896 High Similarity NPC72455
0.8896 High Similarity NPC62640
0.8889 High Similarity NPC226644
0.8889 High Similarity NPC37226
0.8889 High Similarity NPC178202
0.8882 High Similarity NPC17816
0.8874 High Similarity NPC246903
0.8868 High Similarity NPC219861
0.8854 High Similarity NPC268360
0.8854 High Similarity NPC296957
0.8854 High Similarity NPC65504
0.8854 High Similarity NPC260902
0.8854 High Similarity NPC19097
0.8846 High Similarity NPC148938
0.8844 High Similarity NPC29638
0.8839 High Similarity NPC5871
0.8839 High Similarity NPC67654
0.8824 High Similarity NPC266743
0.882 High Similarity NPC193881
0.882 High Similarity NPC67450
0.882 High Similarity NPC277480
0.882 High Similarity NPC155264
0.882 High Similarity NPC210460
0.8812 High Similarity NPC179464
0.88 High Similarity NPC22467
0.8797 High Similarity NPC472877
0.8797 High Similarity NPC476349
0.8797 High Similarity NPC476350
0.8797 High Similarity NPC250076
0.8782 High Similarity NPC235333
0.8782 High Similarity NPC72370
0.8774 High Similarity NPC115324
0.8774 High Similarity NPC156244
0.8766 High Similarity NPC37208
0.8766 High Similarity NPC317492
0.8766 High Similarity NPC221868
0.8766 High Similarity NPC266499
0.8766 High Similarity NPC296030
0.8766 High Similarity NPC39929
0.8758 High Similarity NPC130581
0.8758 High Similarity NPC12148
0.8758 High Similarity NPC37183
0.875 High Similarity NPC155144
0.875 High Similarity NPC98926
0.875 High Similarity NPC208584
0.875 High Similarity NPC234536
0.875 High Similarity NPC78612
0.8742 High Similarity NPC51146
0.8742 High Similarity NPC166858
0.8742 High Similarity NPC313036
0.8734 High Similarity NPC96342
0.8734 High Similarity NPC212967
0.8734 High Similarity NPC246647
0.8734 High Similarity NPC164110
0.8734 High Similarity NPC269495
0.8726 High Similarity NPC213936
0.8726 High Similarity NPC278010
0.8726 High Similarity NPC250769
0.8726 High Similarity NPC297531
0.8726 High Similarity NPC295608
0.8726 High Similarity NPC99199
0.872 High Similarity NPC248593
0.872 High Similarity NPC157522
0.872 High Similarity NPC28589
0.8718 High Similarity NPC207624
0.8716 High Similarity NPC254741
0.871 High Similarity NPC167576
0.871 High Similarity NPC37348
0.871 High Similarity NPC101957
0.871 High Similarity NPC120105
0.8701 High Similarity NPC135325
0.8701 High Similarity NPC37135
0.8701 High Similarity NPC168085
0.8701 High Similarity NPC186397
0.8701 High Similarity NPC272194
0.8696 High Similarity NPC109180
0.8696 High Similarity NPC472581
0.8693 High Similarity NPC300267
0.8693 High Similarity NPC210826
0.8693 High Similarity NPC51641
0.8688 High Similarity NPC30655
0.8688 High Similarity NPC45124
0.8688 High Similarity NPC74854
0.8684 High Similarity NPC225884
0.8684 High Similarity NPC302181
0.8679 High Similarity NPC40583
0.8671 High Similarity NPC45131
0.8671 High Similarity NPC180924
0.8667 High Similarity NPC310794
0.8662 High Similarity NPC131725
0.8662 High Similarity NPC472408
0.8662 High Similarity NPC128961
0.8659 High Similarity NPC131866
0.8654 High Similarity NPC58668
0.8654 High Similarity NPC193976
0.8654 High Similarity NPC23668
0.8654 High Similarity NPC106372
0.865 High Similarity NPC50394
0.865 High Similarity NPC247973
0.8645 High Similarity NPC223988
0.8642 High Similarity NPC291110
0.8642 High Similarity NPC136641
0.8639 High Similarity NPC292998
0.8636 High Similarity NPC205522
0.8627 High Similarity NPC230943
0.8627 High Similarity NPC179970
0.8625 High Similarity NPC169
0.8625 High Similarity NPC304839
0.8625 High Similarity NPC220582
0.8625 High Similarity NPC49009
0.8625 High Similarity NPC243509
0.8625 High Similarity NPC298093
0.8623 High Similarity NPC472606
0.8618 High Similarity NPC53192
0.8616 High Similarity NPC270044
0.8616 High Similarity NPC196448
0.8599 High Similarity NPC142308
0.8599 High Similarity NPC166201
0.8591 High Similarity NPC161196
0.859 High Similarity NPC155882
0.8581 High Similarity NPC10304
0.8581 High Similarity NPC63256
0.8571 High Similarity NPC188486
0.8571 High Similarity NPC14822
0.8571 High Similarity NPC195919
0.8571 High Similarity NPC215932
0.8571 High Similarity NPC231013
0.8571 High Similarity NPC216314
0.8571 High Similarity NPC110639
0.8571 High Similarity NPC182428
0.8571 High Similarity NPC40818
0.8571 High Similarity NPC24761
0.8571 High Similarity NPC258331
0.8571 High Similarity NPC106461
0.8571 High Similarity NPC120924
0.8571 High Similarity NPC216092
0.8571 High Similarity NPC14958
0.8562 High Similarity NPC189650
0.8562 High Similarity NPC196879
0.8562 High Similarity NPC16935
0.8562 High Similarity NPC33320
0.8554 High Similarity NPC233956
0.8553 High Similarity NPC180340
0.8553 High Similarity NPC254010
0.8545 High Similarity NPC144288
0.8544 High Similarity NPC186507
0.8543 High Similarity NPC136095
0.8543 High Similarity NPC262635
0.8543 High Similarity NPC11566
0.8533 High Similarity NPC259685
0.8526 High Similarity NPC238366
0.8519 High Similarity NPC84515
0.8519 High Similarity NPC312056
0.8519 High Similarity NPC273021
0.8519 High Similarity NPC81679
0.8519 High Similarity NPC18284
0.8516 High Similarity NPC471285
0.8516 High Similarity NPC85233
0.8514 High Similarity NPC223354
0.8509 High Similarity NPC239270
0.8509 High Similarity NPC260296

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC233776 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9167 High Similarity NPD1247 Approved
0.9007 High Similarity NPD920 Approved
0.8874 High Similarity NPD642 Clinical (unspecified phase)
0.8742 High Similarity NPD643 Clinical (unspecified phase)
0.8625 High Similarity NPD5494 Approved
0.8591 High Similarity NPD2796 Approved
0.8562 High Similarity NPD919 Approved
0.8543 High Similarity NPD1243 Approved
0.8387 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD7411 Suspended
0.8225 Intermediate Similarity NPD6559 Discontinued
0.8199 Intermediate Similarity NPD2801 Approved
0.8199 Intermediate Similarity NPD7819 Suspended
0.8199 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD1510 Phase 2
0.8153 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8148 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD3926 Phase 2
0.8117 Intermediate Similarity NPD1549 Phase 2
0.8052 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD3749 Approved
0.8025 Intermediate Similarity NPD1934 Approved
0.8012 Intermediate Similarity NPD4380 Phase 2
0.7988 Intermediate Similarity NPD3882 Suspended
0.7976 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD1511 Approved
0.7975 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7949 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD2344 Approved
0.7927 Intermediate Similarity NPD3817 Phase 2
0.7914 Intermediate Similarity NPD6801 Discontinued
0.7904 Intermediate Similarity NPD6959 Discontinued
0.7895 Intermediate Similarity NPD1240 Approved
0.7882 Intermediate Similarity NPD3818 Discontinued
0.7875 Intermediate Similarity NPD1512 Approved
0.7862 Intermediate Similarity NPD6799 Approved
0.7834 Intermediate Similarity NPD2800 Approved
0.7831 Intermediate Similarity NPD7075 Discontinued
0.7821 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD1471 Phase 3
0.7818 Intermediate Similarity NPD5402 Approved
0.7806 Intermediate Similarity NPD3748 Approved
0.7792 Intermediate Similarity NPD1607 Approved
0.7778 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7768 Phase 2
0.7756 Intermediate Similarity NPD2935 Discontinued
0.7736 Intermediate Similarity NPD2309 Approved
0.7733 Intermediate Similarity NPD5844 Phase 1
0.773 Intermediate Similarity NPD3226 Approved
0.7725 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD2533 Approved
0.7702 Intermediate Similarity NPD2534 Approved
0.7702 Intermediate Similarity NPD2532 Approved
0.7683 Intermediate Similarity NPD6599 Discontinued
0.7661 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD6166 Phase 2
0.7661 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD2313 Discontinued
0.7647 Intermediate Similarity NPD6232 Discontinued
0.7643 Intermediate Similarity NPD1551 Phase 2
0.7616 Intermediate Similarity NPD7473 Discontinued
0.7607 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD3750 Approved
0.756 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD6808 Phase 2
0.7529 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6280 Approved
0.7485 Intermediate Similarity NPD5401 Approved
0.7485 Intermediate Similarity NPD6279 Approved
0.7484 Intermediate Similarity NPD2346 Discontinued
0.7468 Intermediate Similarity NPD2799 Discontinued
0.7458 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7229 Phase 3
0.7429 Intermediate Similarity NPD7054 Approved
0.7419 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD6832 Phase 2
0.7394 Intermediate Similarity NPD5403 Approved
0.7389 Intermediate Similarity NPD8434 Phase 2
0.7386 Intermediate Similarity NPD7472 Approved
0.7386 Intermediate Similarity NPD7074 Phase 3
0.7358 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD5953 Discontinued
0.7345 Intermediate Similarity NPD6797 Phase 2
0.733 Intermediate Similarity NPD7286 Phase 2
0.732 Intermediate Similarity NPD3267 Approved
0.732 Intermediate Similarity NPD3266 Approved
0.7303 Intermediate Similarity NPD7251 Discontinued
0.7284 Intermediate Similarity NPD2654 Approved
0.7267 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7808 Phase 3
0.7257 Intermediate Similarity NPD2403 Approved
0.7235 Intermediate Similarity NPD5761 Phase 2
0.7235 Intermediate Similarity NPD5760 Phase 2
0.7219 Intermediate Similarity NPD5889 Approved
0.7219 Intermediate Similarity NPD5890 Approved
0.7215 Intermediate Similarity NPD943 Approved
0.7212 Intermediate Similarity NPD7390 Discontinued
0.7193 Intermediate Similarity NPD5616 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD2296 Approved
0.7176 Intermediate Similarity NPD6844 Discontinued
0.7161 Intermediate Similarity NPD2798 Approved
0.7151 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD5711 Approved
0.7143 Intermediate Similarity NPD5710 Approved
0.7135 Intermediate Similarity NPD1465 Phase 2
0.7125 Intermediate Similarity NPD6651 Approved
0.712 Intermediate Similarity NPD4287 Approved
0.7107 Intermediate Similarity NPD4307 Phase 2
0.7089 Intermediate Similarity NPD3268 Approved
0.7089 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD3751 Discontinued
0.7066 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD1933 Approved
0.7059 Intermediate Similarity NPD6585 Discontinued
0.7053 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7051 Intermediate Similarity NPD1019 Discontinued
0.7043 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD17 Approved
0.7037 Intermediate Similarity NPD7033 Discontinued
0.703 Intermediate Similarity NPD4628 Phase 3
0.7027 Intermediate Similarity NPD1241 Discontinued
0.7027 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD4361 Phase 2
0.7021 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD3972 Approved
0.7 Intermediate Similarity NPD1729 Discontinued
0.7 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.6994 Remote Similarity NPD6100 Approved
0.6994 Remote Similarity NPD6099 Approved
0.6989 Remote Similarity NPD7199 Phase 2
0.6987 Remote Similarity NPD1203 Approved
0.6981 Remote Similarity NPD1296 Phase 2
0.6968 Remote Similarity NPD4360 Phase 2
0.6968 Remote Similarity NPD4363 Phase 3
0.6962 Remote Similarity NPD4908 Phase 1
0.6957 Remote Similarity NPD447 Suspended
0.6957 Remote Similarity NPD230 Phase 1
0.6949 Remote Similarity NPD3787 Discontinued
0.6933 Remote Similarity NPD4308 Phase 3
0.6928 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6923 Remote Similarity NPD1876 Approved
0.6919 Remote Similarity NPD7615 Clinical (unspecified phase)
0.691 Remote Similarity NPD7184 Clinical (unspecified phase)
0.691 Remote Similarity NPD5242 Approved
0.6908 Remote Similarity NPD1548 Phase 1
0.6905 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6903 Remote Similarity NPD9717 Approved
0.6903 Remote Similarity NPD1608 Approved
0.6897 Remote Similarity NPD4288 Approved
0.6895 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6875 Remote Similarity NPD3764 Approved
0.6872 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6863 Remote Similarity NPD1651 Approved
0.6848 Remote Similarity NPD8313 Approved
0.6848 Remote Similarity NPD8312 Approved
0.6839 Remote Similarity NPD1610 Phase 2
0.6823 Remote Similarity NPD8285 Discontinued
0.6818 Remote Similarity NPD6971 Discontinued
0.6815 Remote Similarity NPD3225 Approved
0.6813 Remote Similarity NPD4625 Phase 3
0.6796 Remote Similarity NPD7177 Discontinued
0.6796 Remote Similarity NPD2163 Approved
0.6792 Remote Similarity NPD2861 Phase 2
0.679 Remote Similarity NPD2979 Phase 3
0.679 Remote Similarity NPD1612 Clinical (unspecified phase)
0.679 Remote Similarity NPD1613 Approved
0.6788 Remote Similarity NPD5406 Approved
0.6788 Remote Similarity NPD5408 Approved
0.6788 Remote Similarity NPD6780 Approved
0.6788 Remote Similarity NPD6777 Approved
0.6788 Remote Similarity NPD5404 Approved
0.6788 Remote Similarity NPD6781 Approved
0.6788 Remote Similarity NPD6782 Approved
0.6788 Remote Similarity NPD5405 Approved
0.6788 Remote Similarity NPD6776 Approved
0.6788 Remote Similarity NPD6779 Approved
0.6788 Remote Similarity NPD6778 Approved
0.6786 Remote Similarity NPD3295 Clinical (unspecified phase)
0.6782 Remote Similarity NPD37 Approved
0.6776 Remote Similarity NPD1252 Clinical (unspecified phase)
0.6772 Remote Similarity NPD1470 Approved
0.6772 Remote Similarity NPD2797 Approved
0.677 Remote Similarity NPD1699 Clinical (unspecified phase)
0.677 Remote Similarity NPD411 Approved
0.6765 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6761 Remote Similarity NPD4965 Approved
0.6761 Remote Similarity NPD4966 Approved
0.6761 Remote Similarity NPD4967 Phase 2
0.675 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6748 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6748 Remote Similarity NPD5124 Phase 1
0.6739 Remote Similarity NPD3658 Clinical (unspecified phase)
0.6735 Remote Similarity NPD7871 Phase 2
0.6735 Remote Similarity NPD7870 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data